Search for: "Endo Pharmaceuticals Solutions, Inc." Results 1 - 20 of 31
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Aug 2018, 9:59 pm by Patent Docs
By Donald Zuhn -- Last month, in Endo Pharmaceuticals Solutions, Inc. v. [read post]
28 Feb 2014, 8:09 am by Pete Strom
Endo Pharmaceuticals Pays Settlement for Off-Label Marketing of Lidoderm Pain Patch Endo Health Solutions Inc and its subsidiary Endo Pharmaceuticals have agreed to pay $171.9 million to settle False Claims allegations for off-label marketing of their pain patch, Lidoderm. [read post]
24 Feb 2014, 8:37 am by Ben Vernia
According to DOJ’s press release: Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
” Upon paying the settlement amount, Endo and two of its subsidiaries, Endo Pharmaceuticals Inc. and Endo Health Solutions Inc., will fully resolve Florida’s pending opioid-related claims. [read post]
13 Jun 2010, 9:35 pm by Patent Docs
Paddock Laboratories Inc. 1:10-cv-00501; filed June 9, 2010 in the District Court of Delaware • Plaintiffs: Allergan Inc.; Allergan USA Inc.; Allergan Sales LLC; Endo Pharmaceuticals Solutions Inc.; Supernus Pharmaceuticals Inc. [read post]
21 Apr 2022, 3:26 pm by PP&S Team
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
21 Feb 2014, 10:20 am by Mary Jane Wilmoth
The settlements are listed below: Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
6 Mar 2014, 3:25 pm by CSSFIRM.COM
The pharmaceutical company’s American Medical Systems Inc. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/6: Ethicon Endo-Surgery Inc. v. [read post]
17 May 2011, 10:37 pm
Endo Pharmaceuticals appealed three applications related to time-released opioids. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/19: Allergan Inc., Allergan USA Inc., Allergan Sales, LLC, Endo Pharmaceuticals Solutions Inc., Supernus Pharmaceuticals Inc. v. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
10 Aug 2021, 6:20 am by Robert Kraft
” With the “settlements, only three drug manufacturers, Endo Health Solutions, Teva Pharmaceuticals USA and Allergan Finance, remain at trial. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
16 Feb 2018, 2:06 pm by Dean I. Weitzman, Esq.
Also named in the lawsuit were Allergan, Cephalon, Teva Pharmaceuticals, Endo Health Solutions and Endo Pharmaceuticals, Janssen Pharmaceuticals, Johnson & Johnson and Purdue Frederick Co. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog)   Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
1 Jul 2014, 6:16 am by CSSFIRM.COM
Symptoms of low-T include: Loss of libido Decreased muscle mass Fatigue Products affected by the FDA request include AbbVie Inc’s AndroGel, Endo International Plc’s Aveed and Trimel Pharmaceuticals Corp’s Natesto. [read post]